CAS: 1361227-90-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JH-RE-06 REF: TM-T15611CAS: 1361227-90-8 | 99.29% | 46.00 €~1,076.00 € | Wed 08 Jan 25 |
 | JH-RE-06 REF: 3D-LEC22790CAS: 1361227-90-8 | Min. 95% | To inquire | Wed 19 Feb 25 |
JH-RE-06
CAS:1361227-90-8
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ.
Formula:
C20H16Cl3N3O4
Purity:
99.29%
Color and Shape:
Solid
Molecular weight:
468.72
Ref: TM-T15611
| 1mg | 46.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 346.00 € | ||
| 50mg | 606.00 € | ||
| 100mg | 1,076.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
JH-RE-06
CAS:1361227-90-8
JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor …
Formula:
C20H16Cl3N3O4
Purity:
Min. 95%
Molecular weight:
468.72 g/mol
Ref: 3D-LEC22790
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
